Correspondence on 'Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: case-control study'.

Winkler, Martin Sebastian; Korsten, Peter; Binder, Claudia; Tampe, Björn

Winkler, Martin Sebastian; Korsten, Peter; Binder, Claudia; Tampe, Björn.

Winkler MS; Department of Anesthesiology, Emergency and Intensive Care Medicine, University Medical Center Göttingen, Göttingen, Germany.
Korsten P; Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany.
Binder C; Department of Hematology and Medical Oncology, University Medical Center Göttingen, Göttingen, Germany.
Tampe B; Department of Nephrology and Rheumatology, University Medical Center Göttingen, Göttingen, Germany bjoern.tampe@med.uni-goettingen.de.

Ann Rheum Dis ; 2020 Sep 21.

Article in English | MEDLINE | ID: covidwho-788030

Keywords

anti-inflammatory agents; biological therapy; cytokines; immune system diseases; inflammation; non-steroidal

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Type of study: Observational study Language: English Year: 2020 Document Type: Article Affiliation country: Annrheumdis-2020-218836

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google